http://www.vielabio.com
Viela Bio, Inc. Company Intro
Working to redefine the treatment of autoimmune diseases such as Neuromyelitis optica spectrum disorder, kidney transplant rejection and Sjögren’s syndrome.
Industry
Healthcare
Viela Bio, Inc. Headquaters
One MedImmune Way
Gaithersburg,20878
United States
Viela Bio, Inc. Share price
17 May 2023 14:04 GMT
$0
0.0 (0 %)
Viela Bio, Inc. Market cap
$
WMC RANKING
2023
Viela Bio, Inc. # 118
BiotechnologyLatest Viela Bio, Inc. News
28 Nov 2023
Chronic Wound Care Market to Reach US$ 25,042.5 Million by
In March 2021, as part of Horizon Therapeutics plc, AstraZeneca completed the sale of its 26.7% share in Viela Bio, Inc. (Viela). Elevate Your Business...
28 Nov 2023
Chronic Wound Care Market To Reach US$ 25042.5 Million ...
... Inc. Date. 11/28/2023 6:31:36 AM ... In March 2021, as part of Horizon Therapeutics plc, AstraZeneca completed the sale of its 26.7% share in Viela Bio, Inc.
28 Nov 2023
Chronic Wound Care Market to Reach US$ 25,042.5 Million by
The increasing adoption of active therapies is expected to contribute to the chronic wound care market's growth in the forecast period. Future Market...
WMC Market Score
WMC Market to Revenue Score
Viela Bio, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Viela Bio, Inc. | USD | $32,316 | $164,819 | $-128,849 | $ | 118 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Viela Bio, Inc. Social Followers vs Top 4 Industry Competitors
Viela Bio, Inc. Post vs Top 4 Industry Competitors
Viela Bio, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Viela Bio, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Viela Bio, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Viela Bio, Inc. | 0.35 | 0.09 | 0.01 | 0 | 0 | 0 | 0.04 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
